Rockefeller Capital Management
IBB icon

Rockefeller Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Rockefeller Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.1M Sell
136,949
-10,758
-7% -$1.84M 0.04% 404
2025
Q4 		$24.9M Buy
147,707
+21,052
+17% +$3.42M 0.04% 386
2025
Q3 		$18.3M Sell
126,655
-4,880
-4% -$666K 0.04% 439
2025
Q2 		$16.6M Sell
131,535
-11,796
-8% -$1.45M 0.04% 442
2025
Q1 		$18.3M Buy
143,331
+1,480
+1% +$201K 0.05% 389
2024
Q4 		$18.8M Sell
141,851
-4,943
-3% -$695K 0.05% 362
2024
Q3 		$21.4M Sell
146,794
-8,860
-6% -$1.28M 0.06% 317
2024
Q2 		$21.4M Buy
155,654
+36,491
+31% +$4.87M 0.06% 298
2024
Q1 		$16.4M Buy
119,163
+5,800
+5% +$792K 0.05% 377
2023
Q4 		$15.4M Sell
113,363
-463
-0.4% -$56.5K 0.05% 352
2023
Q3 		$13.9M Buy
113,826
+2,470
+2% +$314K 0.05% 344
2023
Q2 		$14.1M Sell
111,356
-95,403
-46% -$12.4M 0.05% 355
2023
Q1 		$26.7M Buy
206,759
+109,917
+114% +$14.4M 0.11% 202
2022
Q4 		$12.7M Buy
96,842
+13,574
+16% +$1.75M 0.06% 319
2022
Q3 		$9.74M Sell
83,268
-6,363
-7% -$790K 0.05% 363
2022
Q2 		$10.5M Sell
89,631
-3,702
-4% -$439K 0.06% 332
2022
Q1 		$12.2M Sell
93,333
-39,201
-30% -$5.11M 0.06% 321
2021
Q4 		$20.2M Buy
132,534
+25,454
+24% +$3.94M 0.09% 220
2021
Q3 		$17.3M Buy
107,080
+4,484
+4% +$755K 0.09% 231
2021
Q2 		$16.8M Buy
102,596
+23,548
+30% +$3.63M 0.09% 232
2021
Q1 		$11.9M Buy
79,048
+3,397
+4% +$540K 0.08% 238
2020
Q4 		$11.5M Buy
75,651
+23,888
+46% +$3.41M 0.09% 215
2020
Q3 		$7.01M Buy
51,763
+14,119
+38% +$1.92M 0.07% 230
2020
Q2 		$5.15M Buy
37,644
+13,428
+55% +$1.71M 0.05% 241
2020
Q1 		$2.61M Buy
24,216
+2,994
+14% +$345K 0.03% 301
2019
Q4 		$2.56M Buy
21,222
+6,768
+47% +$755K 0.03% 304
2019
Q3 		$1.44M Buy
14,454
+3,317
+30% +$347K 0.02% 336
2019
Q2 		$1.22M Sell
11,137
-1,472
-12% -$157K 0.02% 320
2019
Q1 		$1.41M Buy
12,609
+11,646
+1,209% +$1.28M 0.02% 319
2018
Q4 		$93K Buy
+963
New +$102K ﹤0.01% 462
2018
Q2 		– Sell
-7,500
Closed -$801K – 778
2018
Q1 		$801K Buy
+7,500
New +$831K 0.01% 235

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rockefeller Capital Management's IBB Position: Q1 2026 in Review

Rockefeller Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 7.3% in Q1 2026, selling an estimated $1.84M and leaving 136,949 shares worth $23.1M. The position accounts for 0.04% of the portfolio, ranked #404.

Rockefeller Capital Management first reported a position in IBB in Q1 2018 and has held it in 31 quarters since. The position peaked at $26.7M in Q1 2023. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Rockefeller Capital Management held 136,949 shares of iShares Biotechnology ETF worth $23.1M as of Q1 2026.
  • Rockefeller Capital Management sold 10,758 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.84M.
  • iShares Biotechnology ETF made up 0.04% of Rockefeller Capital Management's portfolio in Q1 2026, its #404 holding.
  • Rockefeller Capital Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 31 quarters since.
  • Rockefeller Capital Management's iShares Biotechnology ETF position peaked at $26.7M in Q1 2023.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.